Home › Neurologic Diseases › Alabama
Neurologic Diseases clinical trials in Alabama
5 studies for Neurologic Diseases are looking for participants at sites in Alabama.
Cities in Alabama
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Birmingham, Alabama, Birmingham
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Oct 2, 2026 · NCT07598708Product Surveillance Registry
- Birmingham
- Huntsville
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Anniston
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 15, 2026 · NCT06916806HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388Rett Syndrome Registry
- University of Alabama, Birmingham
RecruitingObservational study
Ages 0 to 99 · All sexes · Updated Jun 30, 2026 · NCT05432349From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.